Monica Noether is a panelist during GMU conference: Global antitrust challenges in the pharmaceutical sector. Her topic is entitled, “Merger Control in the Pharmaceutical Industry.”
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
